Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Interview Title: Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Confirmed Thought Leader: Stefan Schiesser, Director Medicinal Chemistry, AstraZeneca

Panel Discussion Title: “Accelerating the Future of PROTACs and Molecular Glues: Discovery, Development, and Translational Horizons"

• Towards the Rational Discovery of Molecular Glues: Pitfalls and Successful Strategies for Molecular Glue Discovery and Optimisation
• The Impact of New Technologies and AI on Molecular Glue Discovery and Optimisation
• Comparative Insights: PROTACs vs. Molecular Glues
• The Emerging Frontier: Antibody–Degrader Conjugates
• Key Considerations for Translating PROTACs to the Clinic

Panellists: TBD

To attend this Thought Leadership session you need to be a Premium LifeScienceXchange member.

Secure all the benefits and sign-up for Premium membership now

*If you’re already a Premium member your exclusive invite will be sent direct to your inbox